If somatotrophs are damaged or pituitary blood flow is poor, peptide responsiveness declines
Data Availability All data supporting the findings of this study are available within the paper and its Supplementary Information
It highlights the autologous nature of PRP, its ability to accelerate healing and improve outcomes through the release of GFs
This is general information, not medical advice
Retatrutide is Eli Lilly's triple agonist - one weekly injection that hits three receptors at once (GLP-1, GIP, glucagon)
The growth hormone secretagogue receptor subtype 1a , is a Gq/11-coupled GPCR expressed at highest density in pituitary somatotroph cells and hypothalamic arcuate nucleus neurones, with peripheral expression in stomach, heart, liver, adipose tissue, and immune cells